Zobrazeno 1 - 10 of 51 pro vyhledávání: '"FA Vyth-Dreese"'
3
Akademický článek
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy.
Autor: Nowak-Sliwinska P; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands. Patrycja.Nowak-Sliwinska@unige.ch.; School of Pharmaceutical Sciences, Faculty of Sciences, University of Geneva, Patrycja Nowak-Sliwinska, Rue Michel-Servet 1, CMU, 1211, Geneva 4, Switzerland. Patrycja.Nowak-Sliwinska@unige.ch.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland. Patrycja.Nowak-Sliwinska@unige.ch., van Beijnum JR; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; CimCure BV, Amsterdam, The Netherlands., Griffioen CJ; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Huinen ZR; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Sopesens NG; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Schulz R; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Jenkins SV; Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Dings RPM; Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Groenendijk FH; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands., Huijbers EJM; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; CimCure BV, Amsterdam, The Netherlands., Thijssen VLJL; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Jonasch E; Department of Genitourinary Oncology, MD Anderson Cancer Center, Houston, TX, USA., Vyth-Dreese FA; Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jordanova ES; Center for Gynaecologic Oncology Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands., Bex A; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Surgery and Interventional Science, Royal Free London NHS Foundation Trust, University College London, Pond Street, London, UK., Bernards R; Division of Molecular Carcinogenesis, Oncode Institute, Amsterdam, The Netherlands., de Gruijl TD; Immunotherapy Laboratory, Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands., Griffioen AW; Angiogenesis Laboratory, Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.griffioen@amsterdamumc.nl.; CimCure BV, Amsterdam, The Netherlands. a.griffioen@amsterdamumc.nl.
Publikováno v: Angiogenesis [Angiogenesis] 2023 May; Vol. 26 (2), pp. 279-293. Date of Electronic Publication: 2022 Dec 02.
Zobrazit plný text záznamu
4
Akademický článek
Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.
Autor: Tjin EP; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands e.p.tjin@amc.uva.nl., Krebbers G; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., Meijlink KJ; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., van de Kasteele W; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., Rosenberg EH; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., Sanders J; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., Nederlof PM; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., van de Wiel BA; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., Haanen JB; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the NetherlandsAuthors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., Melief CJ; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., Vyth-Dreese FA; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands., Luiten RM; Authors' Affiliations: Department of Dermatology, Academic Medical Center, University of Amsterdam; Department of Pathology; Molecular Diagnostic Laboratory; Division of Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam; Department of Clinical Oncology, Leiden University Medical Center, Leiden University; and ISA Pharmaceuticals, Leiden, the Netherlands.
Publikováno v: Cancer immunology research [Cancer Immunol Res] 2014 Jun; Vol. 2 (6), pp. 538-46. Date of Electronic Publication: 2014 Mar 10.
Zobrazit plný text záznamu
5
Akademický článek
Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients.
Autor: Griffioen AW; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Mans LA; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., de Graaf AMA; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Nowak-Sliwinska P; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., de Hoog CLMM; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., de Jong TAM; Division of Immunology, Antoni van Leeuwenhoekhuis/The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vyth-Dreese FA; Division of Immunology, Antoni van Leeuwenhoekhuis/The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Beijnum JR; Angiogenesis Laboratory, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Bex A; Department of Urology, Antoni van Leeuwenhoekhuis/The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jonasch E; Department of Genitourinary Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2012 Jul 15; Vol. 18 (14), pp. 3961-3971. Date of Electronic Publication: 2012 May 09.
Zobrazit plný text záznamu
6
Akademický článek
In situ detection of HY-specific T cells in acute graft-versus-host disease-affected male skin after sex-mismatched stem cell transplantation.
Autor: Kim YH; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands., Faaij CM, van Halteren AG, Schrama E, de Jong TA, Schøller J, Egeler RM, Pavel S, Vyth-Dreese FA, van Tol MJ, Goulmy E, Spierings E
Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2012 Mar; Vol. 18 (3), pp. 381-7. Date of Electronic Publication: 2011 Nov 04.
Zobrazit plný text záznamu
7
Akademický článek
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy.
Autor: Tjin EP; Departments of Dermatology, The Netherlands Institute for Pigment Disorders, Academic Medical Center, University of Amsterdam, The Netherlands., Konijnenberg D, Krebbers G, Mallo H, Drijfhout JW, Franken KL, van der Horst CM, Bos JD, Nieweg OE, Kroon BB, Haanen JB, Melief CJ, Vyth-Dreese FA, Luiten RM
Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2011 Sep 01; Vol. 17 (17), pp. 5736-47. Date of Electronic Publication: 2011 Jul 12.
Zobrazit plný text záznamu
8
Akademický článek
Exogenous Addition of Minor H Antigen HA-1+ Dendritic Cells to Skin Tissues Ex Vivo Causes Infiltration and Activation of HA-1-Specific Cytotoxic T Cells.
Autor: Kim YH; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands., Vyth-Dreese FA, Schrama E, Pavel S, Bajema I, Goulmy E, Spierings E
Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2011 Jan; Vol. 17 (1), pp. 69-77. Date of Electronic Publication: 2010 Aug 12.
Zobrazit plný text záznamu
9
Akademický článek
Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.
Autor: Vyth-Dreese FA; Division of Immunology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. f.vyth@nki.nl, Sein J, van de Kasteele W, Dellemijn TA, van den Bogaard C, Nooijen WJ, de Gast GC, Haanen JB, Bex A
Publikováno v: Clinical and experimental immunology [Clin Exp Immunol] 2010 Dec; Vol. 162 (3), pp. 447-59. Date of Electronic Publication: 2010 Oct 05.
Zobrazit plný text záznamu
10
Akademický článek
Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.
Autor: van den Boorn JG; Department of Dermatology, Netherlands Institute for Pigment Disorders, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Konijnenberg D, Dellemijn TA, van der Veen JP, Bos JD, Melief CJ, Vyth-Dreese FA, Luiten RM
Publikováno v: The Journal of investigative dermatology [J Invest Dermatol] 2009 Sep; Vol. 129 (9), pp. 2220-32. Date of Electronic Publication: 2009 Feb 26.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje